Exchange: NASDAQ·Updated 07:30 PM EDT
LTRN logo

LTRN Lantern Pharma Inc

$2.03
$0.04
(1.93%)
Today
Closed $2.03
$0.00
(0.00%)
After Hours
Reported EarningsAug 14
Mkt Cap$26.46M
Vol107,966.00

About LTRN

Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-100, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.
36

Bearish Sentiment

How do you feel about LTRN?

Advertisement|Remove ads.